Both have same life expectancyDr Ghebreyesus noted multiple small trials with different methodologies might not give them clear evidence they need to know which treatment would be needed to save lives. The studies are aimed at generating data that can be used to determine the likely potential of some of the existing drugs to treat Covid-19. Simplified procedures that even smaller hospitals that have been burdened by the crisis can incorporate are being used in these trials. This standard of care is the regular supportive management that hospitals treating Covid-19 patients use. A study in China published by the New England Journal of Medicine, however, concluded that with this ARV, “no benefit was observed beyond standard care.” Further trials might either confirm this or exclude it as a potential treatment for SARS-CoV-2, which causes Covid-19.

Source: Standard Digital March 22, 2020 21:00 UTC